跳至主要内容
临床试验/NCT01977703
NCT01977703已完成不适用

Prospective Randomized Evaluation of an Ultra Conservative Approach to Implantable Defibrillator (ICD) Programming in Patients With a Left Ventricular Assist Device (LVAD).

Vanderbilt University Medical Center1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2013年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
80
试验地点
1
主要终点
Time to first ICD shock following LVAD implant

研究概览

简要总结

We propose to study a strategy empirically applied for the past 6 months at a high volume LVAD center (Vanderbilt Heart and Vascular Institute). This utilizes an ultra conservative device programming strategy to maximize battery longevity, avoid inappropriate implantable cardioverter defibrillator (ICD) therapy, improve quality of life through reduction in overall shock burden, and potentially avoid unnecessary device generator changes prior to transplant. Avoiding CIED (cardiac implantable electronic device) change out device procedures prior to transplant is desirable.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Advanced Heart Failure
  • •Scheduled for Heartmate II LVAD implant
  • •With existing ICD

排除标准

  • 未提供

研究组 & 干预措施

Ultra Conservative ICD Programming

Experimental

ICD will be set to ultra conservative settings post LVAD implant.

干预措施: Ultra Conservative ICD Programming (Other)

Traditional ICD Programming

Active Comparator

ICD will be set to pre-LVAD settings post LVAD implant.

干预措施: Traditional ICD Programming (Other)

结局指标

主要结局

Time to first ICD shock following LVAD implant

时间窗: Within 12 months following LVAD implant

次要结局

  • Frequency of ICD generator change prior to definitive therapy(Within 12 months following LVAD implant)
  • Hospitalization frequency for decompensated congestive heart failure(Within 12 months following LVAD implant)
  • Cardiac implantable electronic device (CIED) battery voltage/estimated longevity changes(Within 12 months following LVAD implant)
  • Frequency of anti-tachycardia pacing (ATP) therapy administration for appropriate or inappropriate arrhythmia detection(Within 12 months following LVAD implant)
  • Frequency of arrhythmic syncope(Within 12 months following LVAD implant)
  • Determine survival to heart transplantation following LVAD implant(Within 12 months following LVAD implant)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Christopher Ellis

Assistant Professor

Vanderbilt University Medical Center

研究点 (1)

Loading locations...

相似试验